By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration is planning to ask Sarepta Therapeutics to voluntarily stop ...

The 'Fast Money' traders recap the recent news moving Sarepta lower and how to play the stock from here. Venezuelans deported by Trump to brutal El Salvador prison are transferred to Caracas in ...

Sarepta (NASDAQ:SRPT) has now seen a third fatal incident in its gene therapy trials due to acute liver failure. That ...

The FDA is set to request Sarepta Therapeutics to halt shipments of its gene therapy, Elevidys, after a third patient's death ...

GlaxoSmithKline LLC (GSK) plans to lay off 150 Cambridge workers. The layoffs come months after GSK said it had planned to ...

Cryptocurrency firm Bullish on Friday filed for an initial public offering in the United States. Uncertainty surrounding ...